ALR TECHNOLOGIES SG LTD. ALR Technologies SG Ltd. Share Price
Equities
ALRTF
SGXZ33978792
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0129 USD | -15.77% |
|
+26.47% | -35.50% |
| 07-01 | ALR Technologies SG Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2021 | 0.01 0.59 | Sales 2022 * | - | Capitalization | 11.04M 867M |
|---|---|---|---|---|---|
| Net income 2021 | -8M -628M | Net income 2022 * | - | EV / Sales 2021 | 6,924,373,996 x |
| Net Debt 2021 | 19.15M 1.5B | Net cash position 2022 * | - 0 | EV / Sales 2022 * | - |
| P/E ratio 2021 |
-3
x | P/E ratio 2022 * |
-
| Employees | - |
| Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 38.79% |
More Fundamentals
* Assessed data
| 1 day | -15.77% | ||
| 1 week | +26.47% | ||
| Current month | +143.40% | ||
| 1 month | -35.50% | ||
| 3 months | -48.40% | ||
| 6 months | -43.17% | ||
| Current year | -35.50% |
1 week
0.01
0.02
1 month
0.010.02
Current year
0.010.04
1 year
0.010.05
3 years
0.010.28
5 years
0.010.28
10 years
0.000.28
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/07/24 | 0.0129 | -15.77% | 25 000 |
| 02/07/24 | 0.0153 | +52.80% | 50,310 |
| 01/07/24 | 0.01 | +88.68% | 141,000 |
| 28/06/24 | 0.0053 | -47.97% | 107,833 |
| 26/06/24 | 0.0102 | +0.86% | 1,500 |
Delayed Quote OTC Markets, July 03, 2024 at 02:53 pm
More quotes
ALR Technologies Inc. is a data management company. The Company is engaged in the development of a comprehensive approach to diabetes care that includes a Food and Drug Administration (FDA) cleared diabetes management system (the Diabetes Solution), which collects data directly from blood glucose meters (BGM); a patent-pending Predictive A1C algorithm to track treatment success between lab reports; and an FDA-cleared Insulin Dosing Adjustment program. The Company has developed the Diabetes Solution for human health, and the GluCurve, a modified version of the Diabetes Solution, for animal health (GluCurve) from its technology portfolio. The Company has developed its Diabetes Solution, which is a comprehensive approach to diabetes care consisting of data collection, predictive A1C, insulin dosage adjustment suggestions, performance tracking, remote monitoring and diabetes test supplies. Its subsidiaries include ALR Technologies SG Pte. Ltd. and Canada Diabetes Solution Centre Inc.
| 1st Jan change | Capi. | |
|---|---|---|
| -35.50% | 8.43M | |
| +0.91% | 204B | |
| +3.74% | 178B | |
| +28.89% | 156B | |
| +31.66% | 113B | |
| +1.18% | 64.26B | |
| +19.45% | 54.98B | |
| -3.44% | 47.44B | |
| -9.28% | 36.7B | |
| -0.10% | 34.84B |
- Stock Market
- Equities
- ALRTF Stock
